Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Neoplasms of the CNS

  Free Subscription


30.08.2021

1 Am J Clin Oncol
2 BMC Cancer
2 Br J Neurosurg
3 Clin Cancer Res
2 Int J Radiat Oncol Biol Phys
3 J Neurooncol
2 J Neurosurg
1 J Nucl Med
2 Neuro Oncol
1 Neurology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Oncol

  1. UEZONO H, Nam D, Kluger HM, Sznol M, et al
    Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases.
    Am J Clin Oncol. 2021;44:495-501.
    PubMed         Abstract available


    BMC Cancer

  2. KIM YJ, Oh H, Lee SJ, Kim KM, et al
    Prognostic significance of the postoperative prognostic nutritional index in patients with glioblastoma: a retrospective study.
    BMC Cancer. 2021;21:942.
    PubMed         Abstract available

  3. LI Y, Guo D
    Genome-wide profiling of alternative splicing in glioblastoma and their clinical value.
    BMC Cancer. 2021;21:958.
    PubMed         Abstract available


    Br J Neurosurg

  4. ULLMANN M, Guzman R, Mariani L, Soleman J, et al
    The effect of anti-thrombotics on the postoperative bleeding rate in patients undergoing craniotomy for brain tumor.
    Br J Neurosurg. 2021 Aug 23:1-7. doi: 10.1080/02688697.2021.1968340.
    PubMed         Abstract available

  5. GONZALEZ L, Castro S, Villa E, Zomosa G, et al
    Surgical resection versus stereotactic radiosurgery on local recurrence and survival for patients with a single brain metastasis: a systematic review and meta-analysis.
    Br J Neurosurg. 2021 Aug 25:1-11. doi: 10.1080/02688697.2021.1950623.
    PubMed         Abstract available


    Clin Cancer Res

  6. SCHRECK KC, Morin A, Zhao G, Allen AN, et al
    Deconvoluting mechanisms of acquired resistance to RAF inhibitors in BRAF V600E mutant human glioma.
    Clin Cancer Res. 2021 Aug 25. pii: 1078-0432.CCR-21-2660.
    PubMed         Abstract available

  7. BOUDREAU CE, Najem H, Ott M, Horbinski C, et al
    INTRATUMORAL DELIVERY OF STING AGONIST RESULTS IN CLINICAL RESPONSES IN CANINE GLIOBLASTOMA.
    Clin Cancer Res. 2021 Aug 25. pii: 1078-0432.CCR-21-1914.
    PubMed         Abstract available

  8. GONZALEZ-BUENDIA E, Zhao J, Wang L, Mukherjee S, et al
    TOP2B enzymatic activity on promoters and introns modulates multiple oncogenes in human gliomas.
    Clin Cancer Res. 2021 Aug 25. pii: 1078-0432.CCR-21-0312.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  9. BERTOLET A, Abolfath R, Carlson DJ, Lustig RA, et al
    Correlation of LET with MRI changes in brain and potential implications for normal tissue complication probability for meningioma patients treated with pencil beam scanning proton therapy.
    Int J Radiat Oncol Biol Phys. 2021 Aug 20. pii: S0360-3016(21)02715.
    PubMed         Abstract available

  10. HUYNH-LE MP, Tibbs MD, Karunamuni R, Salans M, et al
    Microstructural Injury to Corpus Callosum and Intrahemispheric White Matter Tracts Correlate With Attention and Processing Speed Decline After Brain Radiation.
    Int J Radiat Oncol Biol Phys. 2021;110:337-347.
    PubMed         Abstract available


    J Neurooncol

  11. APRA C, Guillemot D, Frouin E, Bouvier C, et al
    Molecular description of meningeal solitary fibrous tumors/hemangiopericytomas compared to meningiomas: two completely separate entities.
    J Neurooncol. 2021 Aug 20. pii: 10.1007/s11060-021-03830.
    PubMed         Abstract available

  12. SEARS TK, Horbinski CM, Woolard KD
    IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat.
    J Neurooncol. 2021 Aug 23. pii: 10.1007/s11060-021-03829.
    PubMed         Abstract available

  13. NOFFSINGER B, Witter A, Sheybani N, Xiao A, et al
    Technical choices significantly alter the adaptive immune response against immunocompetent murine gliomas in a model-dependent manner.
    J Neurooncol. 2021 Aug 25. pii: 10.1007/s11060-021-03822.
    PubMed         Abstract available


    J Neurosurg

  14. SHIMIZU Y, Gumin J, Gao F, Hossain A, et al
    Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.
    J Neurosurg. 2021 Aug 27:1-11. doi: 10.3171/2021.3.JNS203045.
    PubMed         Abstract available

  15. MORSHED RA, Jiam NT, Wang EJ, Magill ST, et al
    Posterior petrous face meningiomas presenting with Meniere's-like syndrome: a case series and review of the literature.
    J Neurosurg. 2021 Aug 27:1-8. doi: 10.3171/2021.2.JNS203259.
    PubMed         Abstract available


    J Nucl Med

  16. BAG AK, Wing MN, Sabin ND, Hwang SN, et al
    [(11)C]-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence.
    J Nucl Med. 2021 Aug 26. pii: jnumed.120.261891. doi: 10.2967/jnumed.120.261891.
    PubMed         Abstract available


    Neuro Oncol

  17. CICONE F, Cascini GL, Minniti G
    Reply to: "Letter to the Editor: Assessment of imaging biomarkers in the follow-up of brain metastases after SRS".
    Neuro Oncol. 2021 Aug 24. pii: 6357080. doi: 10.1093.
    PubMed        

  18. DERKS SHAE, Jongen JLM, van den Bent MJ, van der Veldt AAM, et al
    Assessment of imaging biomarkers in the follow-up of brain metastases after SRS.
    Neuro Oncol. 2021 Aug 24. pii: 6357079. doi: 10.1093.
    PubMed        


    Neurology

  19. BERZERO G, Bellu L, Baldini C, Ducray F, et al
    Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors.
    Neurology. 2021;97:e673-e683.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: